Approvals/TGA/MAVIRET glecaprevir/pibrentasvir 100 mg/40 mg film-coated tablet blister pack

Approved

STANDARD

MAVIRET glecaprevir/pibrentasvir 100 mg/40 mg film-coated tablet blister pack

AbbVie Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: e9b889eec54e84a7
Product Name: MAVIRET glecaprevir/pibrentasvir 100 mg/40 mg film-coated tablet blister pack
Artg Id: 284948
Artg Name: MAVIRET glecaprevir/pibrentasvir 100 mg/40 mg film-coated tablet blister pack
Sponsor: AbbVie Pty Ltd
Company Detail Path: /organization/abbvie-pty-ltd
Artg Date: 2018-01-02
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/e0186bd6e96d38804e509f377c5fb411.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/9a040e456036049ca312b1c60c01f043.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

e9b889eec54e84a7

Type

Standard